查詢結果分析
相關文獻
- Double-Blind Placebo-Controlled Study of Oxatomide in the Treatment of Childhood Asthma
- 環境生態和遺傳與兒童氣喘
- 國小學生氣喘篩檢研究--ISAAC錄影帶問卷和書面問卷之比較
- Diagnosis of Childhood Asthma
- 兒童氣喘的治療指引--世界衛生組織(GINA)與衛生署版
- 食物與兒童氣喘的關係
- Childhood Asthma: Aspects of Global Environment, Genetics and Management
- 脈診儀對氣喘病診斷及嚴重程度之研究
- 兒童氣喘--可以預防的兒童呼吸急症嗎?
- 兒童氣喘的治療
頁籤選單縮合
題 名 | Double-Blind Placebo-Controlled Study of Oxatomide in the Treatment of Childhood Asthma=Oxatomide在氣喘兒童之臨床評估 |
---|---|
作 者 | 邱治平; 黃璟隆; 林秦延; 謝文斌; 謝貴雄; | 書刊名 | 中華民國小兒科醫學會雜誌 |
卷 期 | 38:1 民86.01-02 |
頁 次 | 頁14-20+73 |
分類號 | 417.5343 |
關鍵詞 | 兒童氣喘; 嗜酸性白血球陽離子蛋白質; Oxatomide; Childhood asthma; Eosinophil cationic protein; E.C.P; |
語 文 | 英文(English) |
英文摘要 | Oxatomide is an orally active H��-histamine receptor antagonist. It has been demonstrated to have therapeutic efficacy in the treatment of allergic diseases in adults. The aim of this study was to evaluate the efficacy and safety of oxatomide in the treatment of asthma in children. Sixty-four asthmatic children of both sexes, aged between 5 and 16 years, were enrolled in this double-blind, placebo-controlled trial with a duration of 4 months. Patients were randomized chosen to receive either oxatomide with a daily dose of 1 to 2 mg/kg body weight or a placebo twice daily. Clinical evaluations including pulmonary function tests and immunological studies. The patients' impression on the effect of treatment also were recorded during the study. The effects of bronchodilatation and normalizing pulmonary function were observed 2 months after oxatomide treatment. The levels of eosinophil cationic protein and total asthma symptom scores were significantly reduced during treatment with oxatomide. There was no significant change in total IgE or IgG �� before or after treatment in either the treatment or control groups. During the study, two (5.8%) oxatomide treated patients reported slight drowsiness and one (2.9%) reported body weight gain. Routine laboratory tests showed no significant alterations. In conclusion, oxatomide was generally well tolerated in this study and may have the potential of being an effective treatment for childhood asthma. |
本系統中英文摘要資訊取自各篇刊載內容。